Neurocrine Biosciences NBIX Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher PCVX Q1 2026 Earnings Missed Estimates Amid PreRevenue Stage Stock Inches Higher GBLI Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Results Weigh IAG Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism Despite Modest Stock Pullback EIKN Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage COUR Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Positive Outlook